Please login to the form below
SEC
This page shows the latest SEC news and features for those working in and with pharma, biotech and healthcare.
Celgene boosts CAR-T stake again with Bluebird Bio deal
with the US Securities and Exchange Commission (SEC), plus royalties on sales.
Latest news
-
Theranos and its CEO settle 'massive fraud' charges
Theranos and its CEO settle 'massive fraud' charges. SEC says case is a lesson in truth-telling for those seeking to disrupt an industry. ... Jina Choi, director of the SEC’s San Francisco Regional Office, said: “The Theranos story is an important
-
EU starts investigation of Aspen's cancer drug pricing
This is the first time that the EU authorities have investigated a drugmaker for unjustified price increases, although in the US the Securities &Exchange Commission (SEC) has started an investigation into
-
Valeant's ex-CEO and CFO 'could face criminal charges'
Valeant is already under scrutiny by the Securities &Exchanges Commission (SEC) in the US as well as US Attorney's Offices in New York and Massachusetts, but was understandably tight-lipped
-
GSK draws line under Chinese scandal with $20m SEC settlement
GSK draws line under Chinese scandal with $20m SEC settlement. Brings corruption investigation to an end with commitment to ongoing remediation reports. ... The SEC also said it found that GSK's own control measures on payments to speakers at conferences
-
Valeant shares slide on fears of filing default
Pearson has just returned to work at Valeant after an extended illness, returning just as the company revealed it was facing an investigation by the US Securities &Exchange Commission (SEC), which
More from news
Approximately 2 fully matching, plus 60 partially matching documents found.
Latest Intelligence
-
Creating a successful global compliance programme
The importance of effective compliance programmes was highlighted in the DOJ and SEC’s Resource Guide to the US Foreign Corrupt Practices Act, which describes in detail the hallmarks of a
-
Deal Watch January 2018
investors. However, in the meantime the US Securities and Exchange Commission (SEC) has issued a lawsuit against some traders for insider trading based on a series of suspicious transactions that made
-
US health reforms
In March, the Securities and Exchange Commission (SEC) only narrowly blocked this move.
-
Deal Watch - May 2017
Two months later Abbott asked Alere to cancel the transaction because of a SEC inquiry into accounting issues at Alere and offered $30m to $50m compensation. ... Alere rejected the offer. Abbott had been aware of the SEC inquiry before the deal was signed
-
On the road with the millennial HCP
Yeah I'll put Andy on. Just hang on a sec, he's just sorting our next lift.”.
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest appointments
-
Celgene boosts CAR-T stake again with Bluebird Bio deal
with the US Securities and Exchange Commission (SEC), plus royalties on sales.
-
RSA announces three new UK hires
In 2009, de Luis moved to the UK with SEC Recruitment and spent three years focussing on the Spanish pharmaceutical market across a number of functional areas.
-
Scottish cabinet reshuffle sees Alex Neil made health secretary
Commenting on Twitter, Sturgeon said: “ It has been a privilege to have been Health Sec[retary] - my thanks to all the wonderful people I have worked with.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
SALES ACCELERANT
We help companies to engage prim/sec care healthcare professionals more efficiently and effectively to drive sales growth.
-
SEC Pharma
SEC Pharma. Whether its working with pharmaceutical, CRO, biotech organisations medical communications agencies covering Clinical Research, Regulatory Affairs, Biometrics, Pharmacovigilance, Medical Affairs and medical communications; supporting blue
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Featured jobs
-
Account Manager / Account Director
-
Competative
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
-
Account Director
-
Excellent benefits
- Events Manager – Med Comms – Surrey
-
Salary TBC
-
Associate Medical Director
-
Highly Competitive
-
Medical Writers
-
Competitive Salary and Benefits
-
Associate Director
-
£75, 000-90, 000
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
Subscribe to our email news alerts
- Neonatal Ventilators Market to Grow at a 6% CAGR to 2024
- Cardiac Assist Devices Market Set to Exceed US$ 4010 Million By 2023 : Market Study Report
- Artificial Disc Market Set to Register 21.9 % CAGR to 2024: Market Study Report
- Male Infertility Market Growing Swiftly during 2018-2023 – Business News: Market Study Report
- Cell Culture Market Size, Status, Top Players, Trends and Forecast to 2023:Market Study Report
- Dental Laser Market is projected to significant growth from 2018 to 2024: Market Study Report
PMHub
EY Life Sciences
Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...
Latest intelligence
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
- Artificial Intelligence in Healthcare
- Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
Quick links
Infographics
